LOGIN
RCT
ACE Report #12229
Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS
How to Cite
OrthoEvidence. Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS. ACE Report. 2020;9(5):13. Available from: https://myorthoevidence.com/AceReport/Report/12229
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Radiotherapy alone with concurrent chemoradiotherapy plus temozolamide in locally advanced soft tissue sarcoma at Mayo Hospital Lahore: A randomized controlled trial.
JPMA 70: 572. 2020 Apr 1;1:3-1.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty-four patients with soft tissue sarcomas (STS) were randomized to receive radiation therapy only or radiation therapy plus oral temozolomide. The primary outcome of interest was treatment response as measured by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria. Secondary outcomes of interest included the incidence of adverse events. Results revealed a significantly higher i...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.